Comparative omics of CCM signaling complex (CSC).

Area of Science:

• Neuroscience
• Genetics
• Biomarker Discovery

Background:

• Cerebral cavernous malformations (CCMs) are neurovascular disorders characterized by abnormal capillaries, increasing stroke risk.
• Genetic mutations in KRIT1, MGC4607, and PDCD10 are primary causes of familial CCMs.
• Identifying genetic modifiers and biomarkers is crucial for understanding CCM pathogenesis.

Purpose of the Study:

• To identify potential biomarkers and genetic modifiers of CCMs.
• To utilize a global comparative omics approach across in vitro and in vivo models.
• To systematically evaluate effectors, binding partners, and second-layer interactors of the CCM signaling complex (CSC).

Main Methods:

• A comparative omics approach was employed, analyzing genomic, transcriptomic, and proteomic data.
• Multiple CCM-deficient animal models across nine independent studies were utilized.
• Alterations in various signaling cascades were dissected at multiple molecular levels.

Main Results:

• A significant set of genes was identified and validated across multiple independent studies.
• These validated genes play a crucial role in the pathogenesis of CCMs.
• The study highlights the importance of these genes in CCM development.

Conclusions:

• This represents a large-scale comparative omics analysis of CCM deficiencies across diverse models.
• Global alterations in angiogenic and non-angiogenic signaling cascades were investigated.
• Potential biomarker candidates for novel therapeutic strategies in CCMs were identified.